AstraZeneca Dividend yield

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
   GBP per share 
 Price  70.61
 Dividend  2.15
 Earnings  2.48
 Cash-flow  1.61
 Book value  7.43
 Equity  7.95

AstraZeneca is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. AstraZeneca is a company from UK, and his stocks are publicly traded.

AstraZeneca paid a total dividend of 2,821 million GBP last year, for a market value of 92,640 millions (Market Cap 92,604 millions). Dividend per share of AstraZeneca is 2.15 GBP, and his stock market price 70.61 GBP.

According to the chart below, where dividend yield is displayed, AstraZeneca has a dividend yield of 3.05%, which is higher than the amount offered by both the market average and companies from UK. It is also bigger than average of Health Care industry. This high dividend yield might be a sign to worry about the future of the company so deeper analysis is needed.

In addition, you should compare AstraZeneca dividend yield with other Pharmaceuticals and Biotechnology companies or firms from UK.

Dividend yield of AstraZeneca

AstraZeneca Dividend Payout

About the ability of AstraZeneca to maintain his current dividend of GBP 2.15 per share, an amount that accounts for 3.05%, we should study its payout ratio both on earnings and on cash-flows (see chart below). AstraZeneca payout on ernings is currently 86.69%, which is higher than the market average, and companies of Health Care industry, which are 41.08% and 28.42% respectively. Both figures show that AstraZeneca can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of AstraZeneca is GBP 1.61 per share, which is lower than the dividend per share paid by the company of GBP 2.15, so the company does not generate enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of AstraZeneca, compared againt world market average, UK companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

AstraZeneca payout

AstraZeneca Stock performance

Finally, last moth AstraZeneca showed a return of 9.70% compared to a worldwide -0.39% average, and a 0.79% of Health Care firms. Over the last year, the company obtained a 20.40% versus a worldwide performance of a -2.47%. More detailed information can be seen in the following graph for UK and Pharmaceuticals and Biotechnology firms.

AstraZeneca stock and market return

Next companies

Astro Malaysia Holdi. Malaysia. Consumer Services.

Asustek Computer Inc. Taiwan. Technology.

ASX. Australia. Financials.

Atacadao SA. Brazil. Consumer Services.

AT&T. USA. Telecommunications.

Atlantia. Italy. Industrials.

Previous companies

Astra International. Indonesia. Consumer Goods.

Astra Agro Lestari. Indonesia. Consumer Goods.

Astellas Pharmaceuti. Japan. Health Care.

Assurant. USA. Financials.

Assore Ltd. South Africa. Basic Materials.

Assoc British Foods. UK. Consumer Goods.



All rights reserved

 information advertisement legal

Dividends Ranking | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.